High-cost Angiotensin-Converting Enzyme (ACE) inhibitors by all Sub-ICB Locations

Why it matters: All commonly-used ACE inhibitors are now available generically and are low-cost. There is no difference between these generic versions and the more expensive brands, and so it’s important that practices prescribe the most cost-effective version possible.

Description: Prescribing of high-cost ACE inhibitors as a percentage of prescribing of all ACE inhibitors. See the full list of BNF codes used in this measure.

Performance: Loading...


Tagged as: Cardiovascular system, Standard, Cost Saving, Generic prescribing (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.